Astellas Announces Submission of European Marketing Authorisation Application for Enzalutamide for the Treatment of Men – PR Inside

announces the submission of a European marketing authorisation application to the European Medicines Agency (EMA) for enzalutamide (USAN*, MDV3100) for the treatment of men with metastatic castration-resistant prostate cancer who have been previously …

Posted in Uncategorized